Seven Oaks is excited to announce that its brand will be available in Manitoba through Beleave Inc. (CSE:BE) who has been selected by the Manitoba Liquor and Lotteries Corporation (MBLL) to supply cannabis to Manitoba retailers making Seven Oaks one of the first cannabis brands available to consumers upon legalization. The brand is strongly rooted in Manitoba with its founders being proud Metis from Winnipeg and the name itself being a reference to a historical Metis battle site.
“We wanted to develop a brand that was a modern interpretation of the Metis spirit of freedom and adventure. We’re proud to be able to roll-out in our home province on day one. We’re making history,” said Seven Oaks’ Co-FounderGrant McLeod.
Seven Oaks will have three hybrid strains containing limonene and pinene that were selected for their association with uplifting effects. Products will initially include pouches of 1 g and 3.5 g of flower and 1 g pre- rolled joints, while tinctures and half-gram pre-rolled packs will be coming in the near future.
“Seven Oaks is for professionals like myself who use cannabis regularly while having active, productive lives. I’m looking for something uplifting that I can be functional with, not something that’s going to make me too foggy,” said Grant.
Specific details of price and quantities are still being worked out. Seven Oaks will continue to work closely with MBLL, and all other stakeholders to ensure that we collectively deliver a cannabis system that provides professional and responsible access to high quality recreational cannabis.
Seven Oaks’ cannabis supply is coming from Beleave who has a well-established track record of growing superior cannabis without the use of pesticides providing a secure supply of high grade cannabis for the Seven Oaks brand. Beleave Inc. trades on the CSE as BE and the OTCQX as BLEVF.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact firstname.lastname@example.org, or